Birgit Schultes

Birgit Schultes

Company: Intellia Therapeutics

Job title: Senior Vice President, Cell Therapy


Unlocking Allogeneic TCR Therapies to Pursue Wider Treatment Capability 4:15 pm

Achieving a durable allogeneic response to promote tumor persistence Preventing graft versus host disease to inhibit toxicity in vivo Ensuring TCR scalability to addressing off-the-shelf manufacturingRead more

day: Conference Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.